Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.150
-0.080 (-3.59%)
At close: Sep 8, 2026, 4:00 PM EDT
2.190
-0.040 (-1.79%)
After-hours: Sep 8, 2026, 7:59 PM EDT
Intelligent Bio Solutions Revenue
In the fiscal year ending June 30, 2026, Intelligent Bio Solutions had annual revenue of $4.22M with 38.09% growth. Intelligent Bio Solutions had revenue of $1.15M in the quarter ending June 30, 2026, with 35.78% growth.
Revenue (ttm)
$4.22M
Revenue Growth
+38.09%
P/S Ratio
1.54
Revenue / Employee
$70,253
Employees
60
Market Cap
6.51M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.22M | 1.16M | 38.09% |
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.73K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| INVO Fertility | 7.53M |
| Picard Medical | 6.30M |
| Biomerica | 4.45M |
| IceCure Medical | 3.95M |
| VolitionRx | 2.46M |
| Co-Diagnostics | 721.39K |
INBS News
- 7 days ago - Intelligent Bio Solutions announces private placement of up to $15M - TheFly
- 7 days ago - Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - GlobeNewsWire
- 7 days ago - Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 11 days ago - Intelligent Bio Solutions Slides: Investor presentation - Filings
- 20 days ago - Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth - GlobeNewsWire
- 21 days ago - Intelligent Bio Solutions Annual report: Q4 2026 - Filings
- 21 days ago - Intelligent Bio Solutions Earnings release: Q4 2026 - Filings
- 22 days ago - Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - GlobeNewsWire